Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy (Q43036719)

12 November 2017

title

Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy (English)

1 reference

12 November 2017

author name string

Vijayakumar Sukumaran

1

1 reference

12 November 2017

Kenichi Watanabe

2

1 reference

12 November 2017

Punniyakoti T Veeraveedu

3

1 reference

12 November 2017

Rajarajan A Thandavarayan

4

1 reference

12 November 2017

Narasimman Gurusamy

5

1 reference

12 November 2017

Meilei Ma

6

1 reference

12 November 2017

Ken'ichi Yamaguchi

7

1 reference

12 November 2017

Kenji Suzuki

8

1 reference

12 November 2017

Makoto Kodama

9

1 reference

12 November 2017

Yoshifusa Aizawa

10

1 reference

12 November 2017

publication date

10 June 2010

1 reference

12 November 2017

published in

Hypertension Research

1 reference

12 November 2017

volume

33

1 reference

12 November 2017

issue

7

1 reference

12 November 2017

page(s)

695-702

1 reference

Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Angiotensin II type 1 receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Beneficial effects of olmesartan, a novel angiotensin II receptor type 1 antagonist, upon acute autoimmune myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Prevention of salt-induced hypertension and fibrosis by AT1-receptor blockers in Dahl S rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Myocardial fibrosis: functional significance and regulatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Role of angiotensin II in altered expression of molecules responsible for coronary matrix remodeling in insulin-resistant diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Myocardial proteases and matrix remodeling in inflammatory heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Angiotensin II, oxidative stress, and extracellular matrix degradation during transition to LV failure in rats with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Peroxisome proliferation-activated receptor-γ ligands ameliorate experimental autoimmune myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Increased circulating cytokines in patients with myocarditis and cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Angiotensin II Type 1 Receptor Blockade Improves Hyperglycemia-Induced Endothelial Dysfunction and Reduces Proinflammatory Cytokine Release From Leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

7 January 2021

Molecular mechanisms of myocardial remodeling

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

7 January 2021

Rat dilated cardiomyopathy after autoimmune giant cell myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

7 January 2021

Effects of water deprivation on immunoreactive angiotensin II levels in plasma, cerebroventricular perfusate and hypothalamus of the rat

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

7 January 2021

Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

7 January 2021

Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

7 January 2021

Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

7 January 2021

Autoimmune response in chronic ongoing myocarditis demonstrated by heterotopic cardiac transplantation in mice

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

7 January 2021

Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

7 January 2021

Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.67

7 January 2021

Identifiers

DOI

10.1038/HR.2010.67

1 reference

Dimensions Publication ID

12 November 2017

1030202048

0 references

1 reference